SCHEMBL14720274

SCHEMBL14720274

O=C(O)N1CCC(=Cc2ccc(Br)cn2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 1/20 0.39
AKR1C3 P42330 1/20 0.36
GRM5 P41594 1/20 0.36
TSHR P16473 3/20 0.34
POLB P06746 1/20 0.34
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
SRD5A2 P31213 5/20 0.33
RAB9A P51151 1/20 0.32
CTH P32929 1/20 0.32
PANK3 Q9H999 1/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720686 0.81 GRM5 (0.47) GRM5TSHRPOLBLMNASMN1; SMN2
SCHEMBL14720788 0.77 SRD5A2 (0.48) SRD5A2HPGDSRD5A1
SCHEMBL14720636 0.75 CTH (0.33) KDM4ECTHGRIN2DGRIN3BGRIN1
SCHEMBL23528946 0.74 FAAH (0.36) ALDH1A1GRM5SRD5A2CTHGRIN2D
SCHEMBL14721331 0.73 HRH3 (0.45)
SCHEMBL1011754 0.73 FAAH (0.53)
SCHEMBL4714589 0.71 HTT (0.40) ALDH1A1KDM4EPOLBSMN1; SMN2SRD5A2
SCHEMBL13952771 0.70 GRM5 (0.41) GRM5TSHRLMNARAB9A
SCHEMBL20788470 0.70 ALDH1A1 (0.56) ALDH1A1KDM4EAKR1C3TSHRPOLB
SCHEMBL3208482 0.70 AKR1C3 (0.68) ALDH1A1KDM4EAKR1C3LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed